Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 0 | 0 | 0 | 147 | 7,584 |
| Gross Profit | N/A | N/A | N/A | 147 | 7,584 |
| Operating Expenses | 3,233 | 83,951 | 87,559 | 61,088 | 53,016 |
| Operating Income | -3,233 | -83,951 | -87,559 | -60,941 | -45,432 |
| Interest Expense | 3,612 | 2,210 | 2,633 | 1,849 | 1,948 |
| Pre-tax Income | -6,845 | -86,161 | -90,192 | -62,790 | -47,380 |
| Net Income Continuous | -6,845 | -86,161 | -90,192 | -62,790 | -47,380 |
| Net Income | $-6,845 | $-86,161 | $-90,192 | $-62,790 | $-47,380 |
| EPS Basic Total Ops | -40.03 | -30.42 | -44.41 | -37.06 | -34.97 |
| EPS Basic Continuous Ops | -40.03 | -30.59 | -44.43 | -36.95 | -35.10 |
| EPS Diluted Total Ops | -40.03 | -30.42 | -44.41 | -37.06 | -34.97 |
| EPS Diluted Continuous Ops | -40.03 | -30.59 | -44.43 | -36.95 | -35.10 |
| EBITDA(a) | $-3,233 | $-83,278 | $-87,043 | $-60,203 | $-43,968 |